节点文献
TTV感染血清学、原位杂交及干扰素治疗研究
Serological, in situ hybridization study and interferon therapy of TT virus (TTV) infection
【摘要】 目的了解TTV感染状况,探讨TTV致病性及对干扰素治疗的应答。方法采用PCR和原位杂交方法检测血清和肝组织中TTV DNA,回顾分析8例TTV/HCV感染者干扰素治疗后病毒及ALT应答状况。结果各型肝病患者(36.7%~42.8%)和职业供血员(43.2%)TTV感染率均显著高于义务供血员(健康对照人群,5.6%)。部分感染者采用斑点杂交方法可自血清中检出TTV DNA(3/30,10.0%),提示存在较高的血清病毒负荷, 16例慢性非甲~戊型肝炎患者及16例肝炎后肝硬化患者肝组织以原位杂交检测,各6例TTV DNA阳性(37.5%)。 8例TTV/HCV混合感染者经24周疗程干扰素治疗后,6例维持持久ALT应答(停药后24周ALT正常),治疗12周时, 8例血清TTV DNA均阴转,但 2例停药后复阳, ALT无应答的2例患者, HCV RNA呈阳性但TTV DNA阴怀;而TTV DNA阳转的2例患者ALT均维持应答。结论 TTV感染在肝病患者和职业供血员中较普遍, TTV可在肝组织中活跃复制,其对干扰素治疗反应较敏感,TTV/HCV重叠感染时TTV无明显致肝损伤作用。
【Abstract】 Objective Investigate the prevalence of TTV infection and also evaluate its pathogenicity and response to interferon therapy. Methods TTV DNA in sera and liver tissues were detectedduring IFN-α therapy and were retrospectively in patients with chronic hepatitis C superinfected with TTV who received a regime of 24-week IFN-α treatment. Results The prevalence of TTV infection in patients with liver diseases (36.7%-42.8%) and occupational blood donors (health control, 5.6%). TTV DNA in sera of some subjects could be detected with dot blot method (3/30, 10.0%), indicating a relatively higher serum viral load in these subjects. With in situ hybridezation detection, TTV DNA was found in liver in 37.5% patients with non-A to E chronic hepatitis and in patients with posthepatic cirrhosis, respectively. Among 8 patients with hepatitis C virus (HCV) and TTV superinfection, 6 had sustained ALT response after 24 weeks interferon therapy (ALT remained normal within 24 weeks after of IFN withdrawal. TTV DNA was seronegative in all 8 cases at week 12th of IFN treatment. 2 cases, however,were TTV DNA seropositive again after the therapy ceased. Both of the 2 patients without sustained ALT response were TTV DNA seronegative but HCV RNA seropositive. On the other hand, the 2 patients with TTV DNA seropositive again after withdrawal of IFN had ALT responses. Condusion TTV infechon is common in patients with liver diseases and occupational blood donors. TTV may replicate actively in liver. It seems that TTV has no pathogenetic effect on the liver in patients with super infected HCV/TTV TTV seems to be sensihve to IFN therapy.
- 【文献出处】 肝脏 ,Chinese Hepatology , 编辑部邮箱 ,1999年03期
- 【分类号】R373
- 【被引频次】3
- 【下载频次】25